Up Close with Tebentafusp
Last Updated: May 16, 2025
Discover more about tebentafusp-tebn (KIMMTRAK®).
Related Resources:
PQI
PQI: Tebentafusp-tebn (Kimmtrak®) for Patients with Unresectable or Metastatic Uveal Melanoma
Last Updated: 12/12/2024
Perspectives
OncolyticsToday: The Bispecific Antibody Revolution
Author: KELLY BRUNK
Last Updated: 04/01/2024
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)
Last Updated: 04/23/2026
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 07/01/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 07/01/2025
Up Close with Linvoseltamab
Last Updated: 05/16/2025
PQI Podcast
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
S10 E15: From Student to Fellow to Leader: Exploring Pharmacy Fellowships
Last Updated: 06/10/2026
Cladribine, Cytarabine, and Venetoclax
Last Updated: 05/26/2026
Ibrutinib and BR
Last Updated: 05/26/2026
Ibrutinib and Obinutuzumab
Last Updated: 05/26/2026